INMUNE BIO INC. Long-term Debt and Lease Obligation, Current
INMUNE BIO INC. (INMB) had Long-term Debt and Lease Obligation, Current of $430.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-01.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt and Lease Obligation, Current
us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent · last filed 2023-11-01
- 2023-09-30: Long-term Debt and Lease Obligation, Current $430.00K.
- 2023-06-30: Long-term Debt and Lease Obligation, Current $463.00K.
- 2022-12-31: Long-term Debt and Lease Obligation, Current $526.00K.
- 2022-09-30: Long-term Debt and Lease Obligation, Current $607.00K.
| Period end | Long-term Debt and Lease Obligation, Current |
|---|---|
| 2023-09-30 | $430.00K 10-Q · filed 2023-11-01 |
| 2023-06-30 | $463.00K 10-Q · filed 2023-08-07 |
| 2022-12-31 | $526.00K 10-Q · filed 2023-11-01 |
| 2022-09-30 | $607.00K 10-Q · filed 2022-11-02 |
| 2022-06-30 | $645.00K 10-Q · filed 2022-08-03 |
| 2022-03-31 | $684.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $704.00K 10-K · filed 2023-03-02 |
| 2020-12-31 | $160.00K 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |